DG INNOVATE PLC Logo

DG INNOVATE PLC

Develops sustainable technologies for electric mobility and energy storage solutions.

DGI | IL

Overview

Corporate Details

ISIN(s):
GB00BMZ3D204 (+2 more)
LEI:
21380058VQBP76M7TN11
Country:
United Kingdom
Address:
15 VICTORIA MEWS COTTINGLEY BUSINESS PARK, BD16 1PY BINGLEY

Description

DG Innovate PLC is an advanced research and development company pioneering sustainable and environmentally considerate technologies for electric mobility and energy storage. The company focuses on developing proprietary solutions, including ultra-high performance electric drive systems and advanced energy storage materials. Its key product portfolio features the Pareta® e-drive, a novel motor technology designed for electric vehicles. DG Innovate's work targets the sustainable transportation and energy sectors, leveraging its expertise in material science and electric motor innovation to create next-generation solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-01-08 08:00
Pareta E-drive for Marine Applications
English HTML 14.3 KB
2024-01-05 08:00
Director Share Dealings
English HTML 27.7 KB
2023-12-14 08:00
Holding(s) in Company
English HTML 21.4 KB
2023-12-12 11:48
Holding(s) in Company
English HTML 22.5 KB
2023-12-11 08:00
Director Appointments, £2.4m Convertible Fundraise
English HTML 110.4 KB
2023-09-28 18:11
Interim results for the six months ended 30 June 2023
English DOCX 68.8 KB
2023-09-28 08:00
Interim Results
English HTML 289.9 KB
2023-09-05 08:00
DGI showcases EV solutions at CENEX-LCV 2023
English HTML 14.1 KB
2023-08-10 08:00
Block Listing Return
English HTML 17.7 KB
2023-07-31 08:00
Total Voting Rights
English HTML 11.9 KB
2023-07-21 13:12
Holding(s) in Company
English HTML 21.4 KB
2023-07-19 16:00
Result of AGM
English HTML 46.0 KB
2023-06-22 08:00
Conditional Placing and Notice of AGM
English HTML 25.2 KB
2023-04-28 11:38
Annual Report and Financial Statements for the year ended 31 December 2022
English PDF 2.8 MB
2023-04-28 08:00
Final results for the year ended 31 December 2022
English HTML 740.8 KB

Automate Your Workflow. Get a real-time feed of all DG INNOVATE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DG INNOVATE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DG INNOVATE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.